Galecto Inc (GLTO)
0.6751
-0.02
(-3.57%)
USD |
NASDAQ |
May 10, 16:00
0.6751
0.00 (0.00%)
After-Hours: 18:59
Galecto Shareholders Equity (Quarterly): 28.16M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 28.16M |
| December 31, 2023 | 32.33M |
| September 30, 2023 | 37.38M |
| June 30, 2023 | 43.70M |
| March 31, 2023 | 50.33M |
| December 31, 2022 | 61.75M |
| September 30, 2022 | 72.73M |
| June 30, 2022 | 85.06M |
| March 31, 2022 | 101.31M |
| Date | Value |
|---|---|
| December 31, 2021 | 117.22M |
| September 30, 2021 | 129.62M |
| June 30, 2021 | 141.43M |
| March 31, 2021 | 152.57M |
| December 31, 2020 | 165.49M |
| September 30, 2020 | 89.28M |
| June 30, 2020 | 37.07M |
| December 31, 2019 | 48.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
28.16M
Minimum
Mar 2024
165.49M
Maximum
Dec 2020
82.00M
Average
72.73M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Novo Nordisk A/S | 14.31B |
| Genmab A/S | 4.701B |
| Ascendis Pharma A/S | -257.21M |
| Evaxion Biotech AS | -4.739M |
| IO Biotech Inc | 133.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.48M |
| Total Liabilities (Quarterly) | 4.318M |